YUNYING Medicine
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- Undisclosed
Investors
- 2
About YUNYING Medicine
, trading as YINYING Medicine, operates as a healthcare company which focuses on molecular diagnosis of cancer. It has sub-branch offices in Jiaxing, Qinghai, and Gansu. The founder and CEO of the company, Daoyun Zhang, graduated from Johns Hopkins University. The co-founder and CTO of the company, Ziying Gong, graduated from the Chinese Academy of Sciences. The company acquired certifications such as GMP Certificate and High-tech enterprise certification. The company mainly provides tumor gene testing services, which are based on AllNGS™, Alldetect™, and DNAplus™ technologies. AllNGS™ is high specific liquid phase intersection capture technology. DNAplus™ is a plasma free DNA extraction technology used in early tumor screening, immunotherapy decision-making, etc. Yunying Medical has also developed oncolytic virus drugs for pancreatic cancer, colorectal cancer, B-cell lymphoma and melanoma. The company also provides DNA storage tubes, DNA extraction reagents, probe products and other products. The company generates revenue by providing tumor gene testing services, oncolytic virus drugs, and other related products.
Who invested in YUNYING Medicine
2 investors across 2 rounds
See all investors in YUNYING Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about YUNYING Medicine
Who invested in YUNYING Medicine?
YUNYING Medicine has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has YUNYING Medicine raised?
YUNYING Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did YUNYING Medicine last raise money?
YUNYING Medicine's most recent round on record is a Series B, in Mar 2026.
What does YUNYING Medicine do?
, trading as YINYING Medicine, operates as a healthcare company which focuses on molecular diagnosis of cancer.
Where is YUNYING Medicine headquartered?
YUNYING Medicine is headquartered in Shanghai, China.
Which VCs invest in companies like YUNYING Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at YUNYING Medicine's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like YUNYING Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.